OTC · Biotechnology

Evolva Holding S.A. (ELVAY) Stock

$1.16 +0.00% OTC: ELVAY Healthcare

Evolva Holding SA is a Swiss-headquartered firm, established in 2004, that operates internationally, including in the United States. The company focuses on identifying, scientifically exploring, advancing, and bringing to market natural, bio-based ingredients.

Valuation

MetricValue
Price$1.16
Market Cap$518242
P/E Ratio-23.01
P/B Ratio2.52
P/S Ratio0.00
EPS (TTM)$0.14
52-Week High$1.71
52-Week Low$0.90
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-10.72%
ROA-9.66%
ROCE-11.41%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio8.31

Annual Financials (USD)

Metric20202021202220232024
Revenue$8.0M$10.0M$16.0M$9.0M$0
Operating Profit$-25.0M$-42.0M$-40.0M$-92.0M$1.0M
Net Profit$-30.0M$-41.0M$-43.0M$-105.0M$1.0M
EPS$-9.49$-11.72$-10.00$-19.50$0.14
Op Margin-330.3%-425.5%-259.9%-977.4%—

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$167.0M$156.0M$131.0M$10.0M$8.0M
Total Liabilities$22.0M$24.0M$25.0M$4.0M$1.0M
Cash$20.0M$11.0M$5.0M$6.0M$7.0M
Borrowings$9.0M$11.0M$15.0M$0$0

Latest News

Silver prices today, Thursday, July 30, 2026: Silver prices remain below $60, even without a rate increase Yahoo Personal Finance · Jul 30, 2026 Fed's favored inflation gauge shows prices edged down in June but remain high Yahoo Finance · Jul 30, 2026 Carvana stock tumbles as full-year guidance disappoints despite record quarter Yahoo Finance · Jul 30, 2026 Form 8.3 Business Wire · Jul 30, 2026 Russia adds Telegram founder Durov to 'terrorist' blacklist AFP · Jul 30, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-23.0M$-30.0M$-19.0M$-9.0M$-2.0M
Investing Cash Flow$-11.0M$-8.0M$-4.0M$15.0M$7.0M
Financing Cash Flow$10.0M$19.0M$16.0M$-1.0M$0
Net Cash Flow$-20.0M$-9.0M$-6.0M$1.0M$1.0M
Free Cash Flow$-29.0M$-34.0M$-21.0M$-10.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.10
EV / EBITDA-25.56
FCF Yield-7.62%
Quick Ratio8.31
Interest Coverage-54.27
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Evolva Holding S.A.

Evolva Holding SA is a Swiss-headquartered firm, established in 2004, that operates internationally, including in the United States. The company focuses on identifying, scientifically exploring, advancing, and bringing to market natural, bio-based ingredients. These innovative compounds are utilized across a range of sectors, such as the creation of flavors and fragrances, health and wellness products, and protective health solutions. Evolva's diverse product portfolio includes: Veri-te Resveratrol: A plant-derived polyphenol naturally present in grapes, peanuts, cranberries, and other berries. L-Arabinose: A flavoring agent essential for the Maillard reaction. Valencene: An aromatic component found in citrus fruits and derived from citrus. Nootkatone: A grapefruit aroma ingredient produced through the biochemical oxidation of valencene. Vanillin: The principal aromatic constituent extracted from vanilla beans.

Evolva Holding S.A. is headquartered in CH.

Evolva Holding S.A. (ELVAY) stock trades at $1.16 with a market capitalization of $518242. The stock is valued at a price-to-earnings (P/E) ratio of -23.01, price-to-book of 2.52, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.90 and $1.71, and currently trades 32.2% below its 52-week high.

On profitability, Evolva Holding S.A. generates a return on equity (ROE) of -10.72%, return on capital employed of -11.41%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: evonextholdings.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides